Stanford, CA, United States of America

Samuel Strober

This inventor holds 36 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Hematopoietic Cell Transplantation. Top assignee: Leland Stanford Junior University. Active years: 2010-2025.

USPTO Granted Patents = 36 

% Patents Active = 88.9

 

 

Average Co-Inventor Count = 2.1

ph-index = 12

Forward Citations = 247(Granted Patents)


Location History:

  • Portola Valley, CA (US) (2013)
  • Stanford, CA (US) (2010 - 2023)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Hematopoietic Cells
Transplantation Tolerance
Cancer Therapy
Tumor Vaccination
Allogeneic Stem Cells
Anti-Tumor Immunity
Biomarkers
HLA Mismatched Grafts
Asthma Relief
NKT Cell Inhibition
Radiation Immunotherapy
36 patents (USPTO):Explore Patents

Title: Innovations in Cancer Therapy by Samuel Strober

Introduction

Samuel Strober, based in Stanford, CA, is a prominent inventor with a significant portfolio of 35 patents focused on advancements in cancer therapy and transplantation methods. His work has greatly influenced the fields of immunology and regenerative medicine, contributing to innovative treatments that enhance patient outcomes.

Latest Patents

Among his latest patents, Strober has developed groundbreaking methods for tumor vaccination combined with hematopoietic cell transplantation. This invention outlines a comprehensive approach for treating cancer, involving autologous tumor cell vaccination prior to the transplantation of both hematopoietic and immune cells. In another notable patent, he presents methods for the combined transplantation of solid organs and hematopoietic cells in HLA mismatched recipients. This technique establishes tolerance through the development of persistent mixed chimerism, enabling patients to potentially discontinue the use of immunosuppressive drugs after a sufficient period.

Career Highlights

Throughout his career, Strober has assembled a remarkable portfolio of patents that underpin his expertise in cancer treatment and transplantation. His inventions are not only innovative but also serve as vital contributions to ongoing research and clinical applications in his field.

Collaborations

Strober collaborates with respected colleagues such as Robert Lowsky and Alexander Filatenkov. These partnerships foster a collaborative environment aimed at advancing their shared research interests and enhancing the impact of their innovative therapies.

Conclusion

Samuel Strober continues to be a leading figure in the realm of cancer treatment innovations. His extensive research and patented methodologies not only pave the way for new therapeutic strategies but also reflect his dedication to improving patient care and outcomes in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…